Physician profile
Frederick Rothberg
NPI 1033115738
$61,322.50
in general payments reported to CMS, 2019-2025
30 companies · $7,187 in 2025
The $7,187 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $7,146 · 2021: $6,183 · 2022: $9,643 · 2023: $4,244 · 2024: $11K · 2025: $7,187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Consulting Fee: $7,219 · Food and Beverage: $1,698 · Travel and Lodging: $1,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,650.00 |
| Consulting Fee | $7,218.75 |
| Food and Beverage | $1,698.36 |
| Travel and Lodging | $1,423.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $58,443.01 | 2019-2025 | Collagenase Santyl, Na, Grafix |
| Organogenesis INC. | $1,394.90 | 2019-2025 | Puraply, Apligraf, Affinity |
| Musculoskeletal Transplant Foundation INC. | $616.31 | 2019-2022 | |
| Kerecis Limited | $116.94 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $100.13 | 2024-2025 | Nuzyra |
| Novo Nordisk INC | $64.78 | 2022-2023 | Ozempic, Rybelsus |
| Pfizer INC. | $56.52 | 2020-2021 | |
| Convatec INC. | $48.91 | 2023-2025 | |
| Urgo Medical North America, LLC | $43.36 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Abbott Laboratories | $40.76 | 2023 | Proclaim, Freestyle Libre 3 |
| Integra Lifesciences Corporation | $39.66 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Next Science LLC | $35.80 | 2024 | Blastx, Surgx, Xperience |
| Lilly USA, LLC | $31.19 | 2021-2025 | Zepbound, Mounjaro |
| Glaxosmithkline, LLC. | $29.40 | 2022 | |
| Reapplix INC. | $25.11 | 2024 | 3c Patch Kit - Box |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20.80 | 2022 | |
| Biogen, INC. | $18.51 | 2022 | |
| Valeritas, INC. | $17.89 | 2019 | |
| Advanced Oxygen Therapy INC. | $17.10 | 2024 | Topical Oxygen Chamber For Extremities |
| Reprise Biomedical, INC. | $16.37 | 2023 | Miro3d Fibers, Miro3d |
| Janssen Pharmaceuticals, INC | $15.23 | 2020 | |
| Corcept Therapeutics | $15.16 | 2025 | Korlym |
| Melinta Therapeutics, LLC | $14.88 | 2019 | |
| Merck Sharp & Dohme LLC | $14.84 | 2019 | |
| Genentech USA, INC. | $14.60 | 2019 | |
| Amarin Pharma, INC. | $14.58 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.51 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.26 | 2020 | |
| Bausch Health US, LLC | $13.95 | 2020 | |
| Medtronic, INC. | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Rothberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.